Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court upheld his lifetime ban.
???? Read the story here: https://reut.rs/427Hri5
Keep up with the latest news from around the world: https://www.reuters.com/
#News #Reuters #newsfeed #pharma #martinshkreli #daraprim #pharmabro #medicines #pharmaindustry
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
???? Read the story here: https://reut.rs/427Hri5
Keep up with the latest news from around the world: https://www.reuters.com/
#News #Reuters #newsfeed #pharma #martinshkreli #daraprim #pharmabro #medicines #pharmaindustry
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Sign in or sign up to post comments.
Be the first to comment